7 Dec.

ConvergeHEALTH Product Advisory Council: Hear from Vertex Pharmaceuticals on their approach to pricing analytics & state price transparency compliance

At ConvergeHEALTH, we create digitally connected ecosystems comprised of analytics platforms, industry partnerships, and world-class consulting services, all with the unified vision of putting patients at the center of health care.

Tuesday, 01:00 p.m.  ET
Event language: English



Key takeaways

We invite you to join us on Tuesday, December 7 at 1:00 pm EDT for the second edition of our 2021 Product Advisory Council event series to discover how Vertex Pharmaceuticals is working to optimize their pricing decisions with the ConvergeHEALTH Miner™ Access product suite

Learning objectives

During this webinar, participants will:

  • Hear Charlie Flynn, Associate Director of US Market Access at Vertex Pharmaceuticals, discuss how Vertex Pharmaceuticals is anticipating and maintaining compliance with state price transparency regulations by using the ConvergeHEALTH Miner™ Access platform.
  • Discover Vertex Pharmaceuticals’ experience with deploying the ConvergeHEALTH Miner™ Access platform, the lessons learned along the way, and what’s next.
  • Learn more about ConvergeHEALTH’s data analytics solutions for the life sciences industry and how to apply them in innovative ways.


About ConvergeHEALTH’s Product Advisory Council:

We’re excited to announce that ConvergeHEALTH’s annual Product Advisory Council 2021 series will consist of virtual webinars leading up to a live event! The webinars will spotlight industry peers who have successfully implemented ConvergeHEALTH platforms to optimize their services and the value they add to the life sciences and health care industries. The series will conclude with an in-person event in Denver, CO from March 21 – 23, 2022 that will provide the opportunity to hear directly from industry experts and peers, experience product demonstrations, and enjoy fun snow activities.

We hope you can join Vertex Pharmaceuticals and ConvergeHEALTH virtually this December. 


Charlie Flynn:

  • Associate Director, US Market Access, Vertex Pharmaceuticals

David Carlson:

  • Managing Director and Leader of ConvergeHEALTH’s Market Access and Pricing offering, Deloitte Consulting LLP




Tuesday, 7 Dec 2021 01:00 p.m. ET
Share Share event on social